The scenario: You are faced
with a genetic dilemma. Your maternal grandfather died at age
65 of a known, inherited neurodegenerative disease. The HTT
gene, that when
containing extra CAG repeats, encodes
this disease. Currently, there is no cure for this disease.
Presence of the repeat is easily detected by genetic testing. You have 3 other siblings: a brother
who is 30, a brother who is 15, and a sister who is 18. What should one do? What are the basics one should know of the HTT gene and its incurable disease?
Upon finding out that my
maternal grandfather died at the age of 65 of a known, inherited
neurodegenerative disease, I would inform my siblings that he died from
Huntington’s disease that is caused by CAG expanded repeats in the exon 1
region of the HTT gene. This region encodes for a polyglutamine tract that
starts from the N-terminus, which is located 17 residues away (Kraub 2013).
The Huntington Disease and Patient Counseling
The HD is a neuro
degenerative genetic disease. It is characterized by lack of coordination and
involuntary movements. Cognitive problems appear in later stages of disease and
patients’ quality of life deteriorates up to the point where they need 24 hour
assistance. Depression is common among people suffering from the disease.
The Genetic Disorder and Mechanisms of Disease
This genetic defect on
chromosome 4 causes excessive CAG repeats. Usually this repeat occurs 10 to 28
times, however those with this defect causes CAG to be repeated 36 to 120
times. (URAC 2013) This disease is characterized by progressive neuronal cell
death. It progresses over time becoming fatal which lead to his death. It is a
disorder passed down through families in which parts of the brain degenerate. (URAC
2013)
HD is inherited as a
dominate trait so those who inherit homozygous HTT have similar signs as with
those who are heterozygote for HTT including the symptoms, signs, or age of
onset. (Kraub 2013)
Although in most cases
the age of onset is 35 to 50, it is inversely correlated with the length of CAG
expanded repeats. The CAG repeats bind to translation regulatory protein
complex containing MID1, protein phosphatase 2A and 40S ribosomal S6 kinase.
These repeats are translated into elongated polyQ stretches (Tobin 2000).
The size of the CAG
repeat grows when MID1 binds to protein phosphatase 2A protein complex. This
also stimulates the translation of the CAG expansion, protein phosphatase 2A
and mammalian target of rapamycin- dependent manner. The MID1 complex may serve
as a therapeutic target for the treatment of CAG repeat expansion. (Tobin 2000)
The higher the repeat
numbers the lower the ages of onset for individuals. Those with 35 repeats of
HTT or fewer do not develop HD. Individuals with 35 to 39 repeats may or may
not develop Huntington’s disease. Repeats of 40 to 60 develop into HD when the
individual reaches adulthood. In more severe cases, people who have 60 or
greater repeats have onset before 20 years of age. (Kraub 2013)
Symptoms of those living
with HD show altered energy metabolism in brain and muscle. (Kraub 2013).
Clinical symptoms and Quality of Life
Huntington’s disease
causes motor, cognitive, and behavioral dysfunction. Choreatic movements are
usually the first sign of Huntington’s disease. These are irregular,
unpredictable, purposeless, rapid movements that flow randomly from one body
part to another. The first signs also include motor dysfunction of the toes,
fingers, and face. Eye movement abnormalities soon follow with slow saccades. (Tobin
2000)
It is relentlessly
progressive where death occurs 15-20 years after symptom onset. Juvenile onset
includes symptoms such as seizers, and rapidly progressive dementia. (Tobin
2000)
Diagnosis and Treatment
The treatment of HD
consists mainly in treating and alleviating the symptoms and trying to preserve
the quality of life as long as possible. The goal is to slow down the symptoms
and help the person function and live a normal life. Supervision and treatment
(such as DOPA blockers which aid in decreasing abnormal behaviors and
movements) might be needed since depression and suicide are very common among
person with HD. (URAC 2013)
Epidemiology and Prevention
The risk of getting HD
from one parent suffering from HD is 50 percent. Inheriting the HTT gene from a
parent will guarantee that the child will develop the disease at some point in
their lives which will be passed on to their children. (URAC 2013)
Although there is no
cure or no way to stop the disease from getting worse, it is crucial for family
members to have their DNA tested for HD because as the gene is passed down
through family generations, the number of repeats get larger and the risks of
developing HD symptoms at a younger age increases. (URAC 2013)
For my brother that is
30 years of age, will develop symptoms in his mid 30s and 40s. This is the most
common form of HD which is in adult onset. (URAC 2013)
For my 18 year old
brother and 15 year old sister, it will be less likely that they will develop
early onset form of HD there are only a small number of cases that begins in
childhood or
adolescence. (URAC 2013)
Once I have informed my
siblings of our grandfather’s disease, I would encourage them to get tested and
screened for risk of developing HD.
If any of my siblings
were to have high risk or have the disease I would encourage them to get
supportive counseling after the DNA testing whether or not they are
symptomatic.
It is difficult to take
the right steps in the pathogenic pathways of HD since there is no cure for the
disease, as of yet. There are however, therapeutic interventions that target
early steps in a pathogenic chain of events of those with HD. I would make sure
that they are well informed and supported throughout the process.
Kraub, Syllibe, Susann Schweiger, Erich Wanker, Stephanie
Dorne, Rainer Schneider, Nadine Griesche, Ewa Jastrzebwa, Desiree Rutschow, and
Changwei Chen. "Translation of HTT MRNA with Expanded CAG Repeats Is
Regulated by the MID1–PP2A Protein Complex." Translation of HTT MRNA
with Expanded CAG Repeats Is Regulated by the MID1–PP2A Protein Complex
(2013): 1723-2041. Nature. 26 Feb. 2013. Web. 10 Oct. 2013.
Tobin, Allan J., and Ethan R. Signer. "Trends in Cell
Biology - Huntington's Disease: The Challenge for Cell Biologists." Huntington's
Disease: The Challenge for Cell Biologists 10.12 (2000): 531-36. Trends
in Cell Biology - Huntington's Disease: The Challenge for Cell Biologists.
Web. 9 Oct. 2013.
URAC. "Huntington's Disease: MedlinePlus Medical
Encyclopedia." Huntington's Disease (n.d.): n. pag. Medline Plus.
U.S. National Library of Medicine, 22 Mar. 2013. Web. 11 Oct. 2013.
*I do not own these images, they were found on various tumblr sites. Please let me know if any are yours and I will give you credit for them. Thanks so much!
*I do not own these images, they were found on various tumblr sites. Please let me know if any are yours and I will give you credit for them. Thanks so much!